CCL7 and infection: The mouse data suggest that CCL7 blockade may be a useful therapeutic strategy to reduce the infiltration of inflammatory cells into the kidneys, thereby improving AKI, without affecting the systemic mobilization of bone marrow cells, which may contribute to the defense against infection (47).